[Long-term follow-up of permanent neonatal diabetes in Tunisian infant]

Ann Endocrinol (Paris). 2010 Sep;71(4):314-9. doi: 10.1016/j.ando.2009.12.014. Epub 2010 Jun 15.
[Article in French]

Abstract

Neonatal diabetes mellitus is a rare entity defined as hyperglycaemia occurring within the first 3 months of life that lasts for at least 2 weeks and requiring insulin therapy for unforeseeable duration. We report the case of a full-term female infant with permanent neonatal diabetes mellitus, stemming from consanguineous parents, born with severe intra-uterine growth retardation and birth weight of 1400 g. The patient presented on the 15th day of life a severe dehydration with a fever and ponderal loss of 14 %. The biology showed hyperglycaemia to 15 mmol/L, moderate metabolic acidosis, glucosuria and ketonuria. The diagnosis of neonatal diabetes mellitus was reserved, justifying its stake under insulin. Etiologic investigation showed a type HLA-DR4/DR8; anti-insulin antibodies were weakly positive, Langerhans islet cell and anti-GAD antibodies were negative. Abdominal magnetic resonance imaging scans, karyotype, molecular biology and chromatography of amino and organic acids did not show any abnormalities. During the first 2 years of age, the patient presented a big instability of glycaemia having required several hospitalizations. After 12 years of age, the patient is still under insulin with a satisfactory glycaemia balance and her growth is normal. Besides, she presents a microcephaly with a spastic walking. The search of neonatal diabetes mellitus must be systematic in front of any fetal hypotrophy allowing a premature coverage and a good prognosis.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Diabetes Mellitus / diagnosis*
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / immunology
  • Female
  • Fetal Growth Retardation / immunology
  • Follow-Up Studies
  • HLA-DR Antigens / immunology*
  • HLA-DR Serological Subtypes
  • HLA-DR4 Antigen / immunology*
  • Humans
  • Hyperglycemia / drug therapy
  • Hyperglycemia / immunology
  • Hypoglycemic Agents / immunology
  • Hypoglycemic Agents / therapeutic use
  • Infant, Newborn
  • Infant, Very Low Birth Weight / immunology
  • Insulin / immunology
  • Insulin / therapeutic use
  • Insulin Antibodies / blood*
  • Islets of Langerhans / immunology

Substances

  • HLA-DR Antigens
  • HLA-DR Serological Subtypes
  • HLA-DR4 Antigen
  • HLA-DR8 antigen
  • Hypoglycemic Agents
  • Insulin
  • Insulin Antibodies